Optimization of the First Step of Enoxaparin Synthesis by Hydrolytic Depolymerization of Unfractionated Heparin


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

The first step of low-molecular-mass heparin (enoxaparin) preparation by hydrolytic depolymerization of unfractionated heparin was investigated. The step involved chemical reaction of starting heparin and benzethonium chloride in aqueous saline solutions. The number of acid equivalents in unfractionated heparin was shown to increase as the NaCl concentration increased. This was probably related to effects of the solution ionic strength on the heparin macromolecular conformation, which was confirmed using dynamic light scattering. The average size of the observed light-scattering centers in aqueous heparin solutions decreased with increasing NaCl concentration. Rinsing with H2O and not NaCl solutions and application of ultrasonication were recommended to accelerate purification of benzethonium heparinate from starting materials and to reduce the amount of rinse water. The compositions of the produced and purified benzethonium heparinate samples were confirmed using PMR spectroscopy.

作者简介

L. Frumin

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University

编辑信件的主要联系方式.
Email: leflab39@mail.ru
俄罗斯联邦, Moscow, 119571

K. Yur’eva

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University

Email: leflab39@mail.ru
俄罗斯联邦, Moscow, 119571

A. Askretkov

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University

Email: leflab39@mail.ru
俄罗斯联邦, Moscow, 119571

D. Prokhorov

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University

Email: leflab39@mail.ru
俄罗斯联邦, Moscow, 119571

A. Matveev

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University

Email: leflab39@mail.ru
俄罗斯联邦, Moscow, 119571

E. Zhavoronok

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University; Institute of Pharmaceutical Technologies

Email: leflab39@mail.ru
俄罗斯联邦, Moscow, 119571; 21/32 – 1 Skolkovskoe Shosse, Skolkovo, Moscow, 121353

A. Panov

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University; Institute of Pharmaceutical Technologies

Email: leflab39@mail.ru
俄罗斯联邦, Moscow, 119571; 21/32 – 1 Skolkovskoe Shosse, Skolkovo, Moscow, 121353

D. Shatalov

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University; Institute of Pharmaceutical Technologies

Email: leflab39@mail.ru
俄罗斯联邦, Moscow, 119571; 21/32 – 1 Skolkovskoe Shosse, Skolkovo, Moscow, 121353

E. Shnyak

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University; Institute of Pharmaceutical Technologies

Email: leflab39@mail.ru
俄罗斯联邦, Moscow, 119571; 21/32 – 1 Skolkovskoe Shosse, Skolkovo, Moscow, 121353

S. Kedik

M. V. Lomonosov Moscow Institute of Fine Chemical Technology, Moscow Technological University; Institute of Pharmaceutical Technologies

Email: leflab39@mail.ru
俄罗斯联邦, Moscow, 119571; 21/32 – 1 Skolkovskoe Shosse, Skolkovo, Moscow, 121353


版权所有 © Springer Science+Business Media, LLC, part of Springer Nature, 2018
##common.cookie##